Riskpilot← Back to searchSign inGet full accessSynaptive Medical Denmark ApS
APSBankruptCVR 38607154Hammerensgade 1Wholesale of pharmaceutical and medical goods · NACE 4646Est. 2017— employees
Revenue 2021
DKK 0
EBITDA margin
—
Equity ratio
17.0%
Financial strength
Net profit 2021
DKK -3K
+98% vs 2020
| Revenue | DKK 0 | — |
| EBITDA | DKK 0 | — |
| Net profit | DKK -3K | +98% |
| Total assets | DKK 83K | -9% |
| Equity | DKK 14K | -16% |
| Employees | — | — |
Legal name
Synaptive Medical Denmark ApS
CVR number
38607154
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
26. april 2017
Share capital
DKK 50.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Company purpose
Selskabets formål er distribution, salg og logistik vedrørende medicinsk udstyr og software samt hermed beslægtet virksomhed
Address
Hammerensgade 1
Email
service@synaptivemedical.com
- Event
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 87 | 59 | -12 | -33 | 0 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 87 | 59 | -12 | -33 | 0 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | 87 | 59 | -12 | -33 | 0 |
| Net financials | 0 | 0 | -0 | -94 | 0 |
| Profit before tax | 87 | 59 | -12 | -127 | 0 |
| Tax | 19 | 14 | 3 | 3 | 3 |
| Net profit | 68 | 45 | -15 | -130 | -3 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 793 | 430 | 479 | 92 | 83 |
| Equity | 118 | 162 | 147 | 17 | 14 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 675 | 268 | 332 | 75 | 69 |
| Total debt | 675 | 268 | 332 | 75 | 69 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20172021
Equity ratio
17.0%
This company
38.2%
Market median
-55% vs market
20172021
Return on equity
-18.6%
This company
18.4%
Market median
-201% vs market
20172021
Net profit margin
-263700.0%
This company
8.1%
Market median
-3255656% vs market
20172021
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20172021
Debt / equity
4.87×
This company
0.62×
Market median
-685% vs market
20172021
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-04-26 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
GP Management | Management | 2017 | — | — |
PB Unofficial title | Unofficial title | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2019 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2018 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Synaptive Medical Denmark ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| George Peter Dans | Management | 0 companies |
| Pernille Bigaard | Unofficial title | 0 companies |
| Sandra Mae Clarke | Board of Directors | 0 companies |
| Peter Lee Wehrly | Board of Directors | 0 companies |
| Cameron Piron | Chairman | 0 companies |
| Harry Ronald Lester Patterson | Board of Directors | 0 companies |